FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25
Latest In: Stocks
AmeriCann Invests $6.7M in Massachusetts MJ Facilities
AmeriCann, a Denver medical marijuana company, is investing nearly $7 million in a dispensary and a grow facility in…
News April 14MassRoots Taking Another Stab at Nasdaq Listing
MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.…
News April 11
GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry
By Omar Sacirbey A British company that develops cannabis-based medicine is on the verge of a major breakthrough…
News March 30Hustler Publisher Invests in Ancillary MMJ Company
The cannabis industry is attracting investors from all walks of life. Including porn. Larry Flynt, the famed publisher…
News March 25Study Results Send GW Pharma’s Stock Soaring
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine…
News March 14
Oakland Dispensary Shares To Be Publicly Traded
By Omar Sacirbey Following a brutal 2015 for marijuana stocks, the cannabis investment sector has something to smile…
News January 13
Chart of the Week: Cannabis Stocks End 2015 With Bumps, Bruises
By Becky Olson Last year was a tumultuous one for cannabis stocks, further deterring institutional investors from getting involved…
News January 11Medicine Man Technologies Nears Stock Listing
Medicine Man Technologies, a Colorado-based cannabis consulting firm tied to the family behind two high-profile marijuana stores, received clearance…
News December 24
Week in Review: CBD Setback in Florida, Progress for Marijuana Research & Cannabis Stock Slump?
By Omar Sacirbey and John Schroyer Legal challenges threaten to further delay Florida’s CBD program, a new institute in…
News December 18
Latest Sponsored
